Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Conventional cancer treatment modalities are often associated with major therapeutic
limitations and severe side effects. Photodynamic therapy is a localized noninvasive mode …

YAP1-NUTM1 fusion transcripts have been recently reported in poroma and porocarcinoma.
NUTM1 translocation can be screened by nuclear protein in testis (NUT) …

Structural alterations of NUTM1 were originally thought to be restricted to poorly
differentiated carcinomas with variable squamous differentiation originating in the midline …

Primary pulmonary nuclear protein of testis carcinoma is a rare and highly aggressive
malignant tumor. It accounts for approximately 0.22% of primary thoracic tumors and is little …

Methods: The European Cooperative Study Group for Pediatric Rare Tumors developed
recommendations according to the Consensus Conference Standard Operating procedure …

Simple Summary Since T-VEC is already approved for treatment of melanoma, its promising
efficacy shown here also for NUT carcinoma (NC) cell lines may create a rapid transition to …

NUT carcinomas are genetically defined epithelial neoplasms. Most tumors harbor fusions of
NUTM1 with BRD4 or BRD3. Their histopathologic features have been predominantly …

Background NUT carcinoma (NC), previously known as NUT midline carcinoma, is a rare
and very aggressive cancer that occurs in both children and adults. NC is largely …

NUT carcinoma is an aggressive carcinoma with an overall poor survival outcome. The
mediastinum and head and neck area, especially the sinonasal region, are among the …